About the company
Shenzhen Hepalink Pharmaceutical Group Co.,Ltd(Hepalink),distributing its products,Heparin Sodium API,in the global markets and internationally renowned pharmaceutical companies,e.g.Sanofi-Aventis,Fresenius Kabi,and Novartis.
Hepalink was established in 1998 and restructured in 2007 to be a limited liability company. Hepalink went public and was listed on the Shenzhen Stock Exchange on May 6, 2010 (stock code "002399"). Hepalink headquarters are located in the Shenzhen High-Tech Park.